We can all only speculate, but since these type of deals do not occur overnight, it was more than likely known. But let's say it wasn't, then adjust the price accordingly, and it still should be 50% higher than where it currently is. Ah, but there's something missing. The big piece of the puzzle that's missing is the information in the BioMedReport where they "looked through their books" That's an unknown to us in the investing community. Analysts, etc. get peaks at that stuff, we have to wait for it. And we should be skeptical until we see it. But I'll bet that it's coming, because it would be awfully difficult for BMR or Goldman to backtrack on their statements and coverage if there isn't some meat behind it. Millions of people are watching and waiting. Patience, it will come.
